Remuneration

Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders

Retrieved on: 
Thursday, March 28, 2024
Remuneration, BDO, Circular, P.C, Incentive

as the auditor of the Company for the fiscal year ended December 31, 2024 and authorized the Board to fix the auditor’s remuneration.

Key Points: 
  • as the auditor of the Company for the fiscal year ended December 31, 2024 and authorized the Board to fix the auditor’s remuneration.
  • The Company’s shareholders have approved the 2024 Equity Incentive Plan of the Company (the “Incentive Plan”), ‎pursuant to which the Company is able to issue share-based long-term incentives.
  • All directors, officers, employees ‎and service providers of the Company and/or its affiliates ‎‎are eligible to receive awards under the Incentive Plan, subject to the ‎terms of the Incentive Plan.
  • Awards include common share purchase options, stock appreciation rights, restricted share awards, restricted share bonuses, restricted share units, performance shares, performance units, cash-based awards, and other share-based awards under the Incentive Plan.

Sword Group: NOTICE OF CONVOCATION TO THE SHAREHOLDERS FOR THE ANNUAL ORDINARY GENERAL MEETING OF THE COMPANY

Retrieved on: 
Thursday, March 28, 2024
Remuneration, Approval, Proxy, Mass meeting, Policy, Bank statement, Confidentiality, Security (finance)

Shareholders have the right to ask questions regarding items on the agenda of the General Meeting.

Key Points: 
  • Shareholders have the right to ask questions regarding items on the agenda of the General Meeting.
  • The Ordinary General Meeting will validly deliberate on the agenda items if at least 25% of the issued share capital is present or represented.
  • The Extraordinary General Meeting will validly deliberate on the agenda items if at least 50% of the issued share capital is represented.
  • This notice shall serve as a notice of convocation unless any modifications are made to the agenda following requests for the inclusion of resolution proposals submitted by shareholders.

LEADING EDGE MATERIALS ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD THURSDAY, APRIL 25, 2024

Retrieved on: 
Wednesday, March 27, 2024
Remuneration, Computershare, 14th Floor Records, Notice, Corporation, Euroclear, CDS, FRA, Bank statement

The record date for the Meeting is March 19, 2024.

Key Points: 
  • The record date for the Meeting is March 19, 2024.
  • The Notice of Meeting, the accompanying Management Proxy Circular and related meeting materials are available under the Company’s profile on SEDAR at www.sedar.com and on the Company’s website at https://leadingedgematerials.com/ .
  • The information in this section is of significance to Shareholders who hold their securities (“Euroclear Registered Securities“) through Euroclear Sweden AB, which securities trade on the Nasdaq First North.
  • Shareholders who hold Euroclear Registered Securities are not registered holders of voting securities for the purposes of voting at the Meeting.

Endeavour Announces Completion of Investigation and Key Findings

Retrieved on: 
Wednesday, March 27, 2024
Remuneration, Linklaters, Documentation, Ernst & Young, Finance, Risk, Sale, LLP, Interview, Record, Nature, Allied Gold, Investigation, MAR, Bank statement, TSX, OTCQX, M&A, Audit committee, Person, Cryptocurrency

Mr de Montessus provided implausible and untrue explanations of his conduct during the course of the Investigation.

Key Points: 
  • Mr de Montessus provided implausible and untrue explanations of his conduct during the course of the Investigation.
  • Srinivasan Venkatakrishnan (“Venkat”), Chairman of Endeavour, commented: “The Board’s actions illustrate the high importance we place on integrity, governance and transparency.
  • Prior to the conclusion of the investigation work, Mr de Montessus was interviewed for a second time in late February.
  • Despite extensive efforts, the Investigation was not able to establish the ultimate beneficiaries of the payments to this third-party entity.

Standard Uranium Shareholders Approve All Proposals at 2024 Annual General and Special Meeting

Retrieved on: 
Tuesday, March 26, 2024
Remuneration, Special

VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“Standard Uranium” or the “Company”) (TSX-V: STND) (OTCQB: STTDF) (Frankfurt: FWB:9SU) is pleased to announce it held its Annual General and Special Meeting of Shareholders (the “Meeting”) on March 26, 2024.

Key Points: 
  • VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“Standard Uranium” or the “Company”) (TSX-V: STND) (OTCQB: STTDF) (Frankfurt: FWB:9SU) is pleased to announce it held its Annual General and Special Meeting of Shareholders (the “Meeting”) on March 26, 2024.
  • At the Meeting, shareholders voted in favour of all business items including setting the number of directors at six (6) and the re-election of directors: Jon Bey, Neil McCallum, Mike Young, Zoya Shashkova, Blair Jordan and Kenneth Judge.
  • Furthermore, the shareholders have approved the re-appointment and remuneration of Manning Elliott LLP as the Company’s auditor for the ensuing year, the re-approval of the Company’s Omnibus Plan, and the approval of continuance resolution set out in Schedule “C” of the Company’s information circular.

Notice of Annual General Meeting in Starbreeze AB (publ)

Retrieved on: 
Tuesday, April 9, 2024
Remuneration, Annual, PwC, Documentation, Exercise, Committee, Address, Proxy, AB, Euroclear, Starbreeze Studios, Acquisition, Bank statement, Annual general meeting, Swedish, Post office box, Companies Act, Audit committee

556551-8932, are given notice of the Annual General Meeting to be held on Wednesday 15 May 2024 at 13.00 CEST in Styrelserummet, Citykonferensen, Malmskillnadsgatan 46, Stockholm, Sweden.

Key Points: 
  • 556551-8932, are given notice of the Annual General Meeting to be held on Wednesday 15 May 2024 at 13.00 CEST in Styrelserummet, Citykonferensen, Malmskillnadsgatan 46, Stockholm, Sweden.
  • The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the Annual General Meeting also by postal voting.
  • A) Anyone wishing to attend the meeting room in person or through a representative must:
    be listed as a shareholder in the presentation of the share register prepared by Euroclear Sweden AB concerning the circumstances on Monday 6 May 2024, and
    give notice of participation no later than on Wednesday 8 May 2024 to the address Starbreeze AB, "Annual General Meeting 2024", c/o Euroclear Sweden AB, P.O.
  • Completed and signed forms for postal voting can be sent by mail to Starbreeze AB, "Annual General Meeting 2024", c/o Euroclear Sweden AB, P.O.

Notice of Annual General Meeting (AGM) of Bioretec Ltd

Retrieved on: 
Friday, April 5, 2024
Remuneration, Charter, Annual, EUR, Chair, PwC, Nomination, Exercise, Communication, Address, Travel, Mass meeting, Shareholder, Bank statement, Investment company, Annual general meeting, Tax, Companies Act, Chapter Five, Privacy, EET, Holding company

TAMPERE, Finland, April 5, 2024 /PRNewswire/ -- The shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting to be held on 26 April 2024 at 10:00 a.m. (Finnish time) at Bioretec premises in the auditorium of Tampark, at the address Yrittäjänkulma 5, FI-33710 Tampere, Finland.

Key Points: 
  • A shareholder may participate in the Annual General Meeting and exercise their rights at the meeting by way of proxy representation.
  • The authorization is valid until the end of the next Annual General Meeting, however, no longer than until 30 June 2025.
  • The Board of Directors proposes that the Annual General Meeting resolve to establish a shareholders' nomination board ("Nomination Board"), responsible for annually preparing and presenting to the Annual General Meeting and, if necessary, to an Extraordinary General Meeting, proposals on the composition (number of the members of the Board of Directors and the nominees) and remuneration of the Board of Directors.
  • The meeting minutes of the Annual General Meeting will be available on the company's website no later than 10 May 2024.

Notice of Annual General Meeting (AGM) of Bioretec Ltd

Retrieved on: 
Friday, April 5, 2024
Remuneration, Charter, Annual, EUR, Chair, PwC, Nomination, Exercise, Communication, Address, Travel, Mass meeting, Shareholder, Bank statement, Investment company, Annual general meeting, Tax, Companies Act, Chapter Five, Privacy, EET, Holding company

TAMPERE, Finland, April 5, 2024 /PRNewswire/ -- The shareholders of Bioretec Ltd are hereby invited to the Annual General Meeting to be held on 26 April 2024 at 10:00 a.m. (Finnish time) at Bioretec premises in the auditorium of Tampark, at the address Yrittäjänkulma 5, FI-33710 Tampere, Finland.

Key Points: 
  • A shareholder may participate in the Annual General Meeting and exercise their rights at the meeting by way of proxy representation.
  • The authorization is valid until the end of the next Annual General Meeting, however, no longer than until 30 June 2025.
  • The Board of Directors proposes that the Annual General Meeting resolve to establish a shareholders' nomination board ("Nomination Board"), responsible for annually preparing and presenting to the Annual General Meeting and, if necessary, to an Extraordinary General Meeting, proposals on the composition (number of the members of the Board of Directors and the nominees) and remuneration of the Board of Directors.
  • The meeting minutes of the Annual General Meeting will be available on the company's website no later than 10 May 2024.

Philips convenes the Annual General Meeting of Shareholders 2024

Retrieved on: 
Friday, March 22, 2024
Annual, Supervisory board, PHG, AGM, Bank statement, Remuneration, Policy, AEX, Property management

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and published the agenda with explanatory notes.

Key Points: 
  • Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and published the agenda with explanatory notes.
  • Proposals to re-appoint Chairman Feike Sijbesma (Dutch, 1959) and Peter Löscher (Austrian, 1957) as members of the Supervisory Board, with effect from May 7, 2024.
  • Proposal to appoint Benoît Ribadeau-Dumas (French, 1972) as new member of the Supervisory Board, with effect from May 7, 2024.
  • The AGM will be held at the Hotel Hilton Amsterdam, Apollolaan 138, Amsterdam on Tuesday, May 7, 2024, beginning at 14:00 CET.

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Thursday, March 21, 2024
AYA, Research, Remuneration, Civil service commission, Administration, Conference, Net, Growth, Young adult, Fennec, FENC, Patient, Into, G&A, NCCN, Adolescence, Marketing, MHRA, TSX, European Commission, FDA, Pharmaceutical industry

RESEARCH TRIANGLE PARK, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today reported its financial results for the fiscal year ended December 31, 2023 and provided a business update.

Key Points: 
  • ET ~
    RESEARCH TRIANGLE PARK, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today reported its financial results for the fiscal year ended December 31, 2023 and provided a business update.
  • PEDMARQSI was granted EU marketing authorization by the European Commission in June 2023, and received UK approval from the MHRA in October 2023.
  • Achieved PEDMARK net product revenue of approximately $9 million and $21 million for the fourth quarter and full year 2023, respectively.
  • Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2023
    Net Sales – Net product sales of $21.3 million in fiscal 2023 compared to $1.5 million in 2022.